A study analyzing potential for Rodatristat ethyl to reduce CNS 5HT in humans and report incidence of mood changes in healthy human subjects
Latest Information Update: 09 Nov 2023
At a glance
- Drugs Rodatristat ethyl (Primary)
- Indications Idiopathic pulmonary fibrosis; Non-alcoholic fatty liver disease; Pulmonary arterial hypertension
- Focus Adverse reactions
- 09 Nov 2023 New trial record
- 13 Sep 2023 Results presented at the 33rd Annual Congress of the European Respiratory Society